According to the UN and WHO report, by 2050 the proportion of the world's population over 60 years will be 1 to 5 and in Asia it will be even more dramatic 1 to 4.The world's population is rapidly aging, creating urgency to find novel solutions for healthy aging.
With our MioStem Innovation, we are focused on improving and extending healthspan by a minimum of 10 years.Our innovation develops the therapeutic potential of senescent adipose-derived stem cells (ASCs) and their secretome.By administering autologous senescent ASCs, we are promoting tissue rejuvenation and mitigate age-related decline.
MioStem Innovation is affordable technology for isolating, preserving, propagating, and genetically modifying stem cells from adipose tissue, with no future risk of immune rejection.
Starting in 2022, Skin Open Source project created an affordable protocol using stem cells derived from adipose tissue to treat and rehabilitate burn injuries and wounds, providing effective treatment for victims of war in Ukraine.
At Longevity Ukraine with MioStem Innovation, we are turning wartime biotech into peacetime longevity innovation.
We are raising 170,000 EUR to expand and deepen our research and product development, and to conduct planned clinical trials in healthy older adults at a leading research center in Kyiv, Ukraine with collaboration with a team of scientists from the Skin Open Source project in the Q4 2025-Q1 2026. 
We already have our angel lead investor and invite you to invest in our MioStem Innovation.

Longevity Ukraine is a part of the $101M #XPRIZEHealthspan competition!
Between 2015 and 2050, the world's population over 60 years old is expected to almost double from 12% to 22% (or 1 in 5 people) – creating urgency to find novel solutions for healthy aging.We are excited to develop the therapeutic potential of senescent adipose-derived stem cells (ASCs) to make healthy aging possible for everyone. 
Thank you all for your support! Stay tuned as we start bringing our innovations to life.
xprize.org/healthspan

Longevity Ukraine is a part of the ‘Innovating for Asia’s Demographic Future’ Challenge!
This Challenge was launched by financial services giant Manulife through UpLink, the World Economic Forum’s early-stage innovation initiative to tackle the world’s biggest challenges.
‘Innovating for Asia’s Demographic Future’ Challenge calls for innovative solutions that enable multigenerational financial resilience, equitable healthy aging and fulfilment across longer multi-stage lives in Asia.By 2050, one in four people in Asia will be over the age of 60 - creating urgency to find novel solutions for healthy aging.
Stay tuned as Longevity Ukraine is bringing innovations to life with the therapeutic potential of senescent adipose-derived stem cells (ASCs) and their secretome to make healthy aging possible for everyone. 
Our projects and initiatives need financial backing and community support.We are deeply grateful for any assistance.Thank you all for your support!

uplink.weforum.org